A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells()()

The therapeutic effect in non–small cell lung cancer (NSCLC) patients is limited because of intrinsic and acquired resistance. Thus, an unmet need exists for the development of new drugs to improve the therapeutic efficacy in NSCLC patients. In this study, the novel small molecule indolizino[6,7-b]i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neoplasia
Main Authors: Chen, Chi-Wei, Wu, Ming-Hsi, Chen, Yi-Fan, Yen, Tsai-Yi, Lin, Yi-Wen, Chao, Shu-Hsin, Tala, Satishkumar, Tsai, Tung-Hu, Su, Tsann-Long, Lee, Te-Chang
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2016
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840272/
https://ncbi.nlm.nih.gov/pubmed/27108383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados